Serina Therapeutics, Inc. business relationships
Companies named in Serina Therapeutics, Inc.’s 10-K filed 2026-03-25, and public companies whose annual reports name Serina Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- 2 / 100 Top 20% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Serina Therapeutics, Inc.’s annual report 2
“Under the terms of the agreement, Pfizer is authorized to develop, manufacture, market, and commercialize products incorporating the licensed technology with respect to a specific POZ polymer structure in one field.” SEC filing
“In October 2023, Serina entered into a non-exclusive license agreement with Pfizer to use our POZ polymer technology for use in lipid nanoparticle drug delivery formulations.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.